Get the app
US › Healthcare

Sight Sciences Inc (SGHT)

US · Healthcare · Medical Devices

$10.08+3.28%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$24.9M
Revenue YoY
+25.2%
Net profit
$-6.8M
EPS
$-0.12
EPS estimate
$-0.12
Net margin
-27.3%

EPS came in at -0.12 against a street estimate of -0.12 — a beat of 0.0%.

Key statistics

Market cap
$533.3M
Forward P/E
0.0
P/B
9.81
Book value
$1.20
EPS (TTM)
$-0.56
52-week high
$10.30
52-week low
$3.38
50-day MA
$8.63
200-day MA
$6.01
Beta
2.40

Analyst view

Analysts rate Sight Sciences Inc a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $10.17.

Shareholding

Insiders
19.80%
Institutions
49.65%

Largest institutional holders

FundStake
Long Focus Capital Management, LLC6.98%
BlackRock Inc5.60%
Pathstone Holdings LLC3.05%
Vanguard Capital Management, LLC2.86%
B Group, Inc1.76%
Geode Capital Management, LLC1.74%
State Street Corp1.52%
Acadian Asset Management LLC1.46%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sight Sciences Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.